| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| California BanCorp | Director | Common Stock | 45,894 | $939,450 | $20.47 | 01 Aug 2023 | Direct |
| AVEO PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 0 | 19 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017023043479-cullen-kevin-joseph-2023-08-01 | California BanCorp | 01 Aug 2023 | 1 | +$11,997 | 4 | Director | 18 Aug 2023, 17:30 |
| /report/000089924323002188-cullen-kevin-joseph-2023-01-19 | AVEO PHARMACEUTICALS, INC. | 19 Jan 2023 | 2 | $0 | 4 | Director | 19 Jan 2023, 16:14 |
| /report/000162828022016599-cullen-kevin-joseph-2022-06-07 | AVEO PHARMACEUTICALS, INC. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 16:57 |